Invion Secures Non-Dilutive Backing to Advance Cancer Therapy
Invion (ASX:IVX) saw a sharp rerating today, with the share price rising 20% following the announcement of potential non-dilutive funding that meaningfully…
Invion’s Global Photosoft Play Positions It as a Leader in PDT
Invion (ASX: IVX) surged 37% today after announcing it has secured perpetual, exclusive global rights to the Photosoft™ therapy…
The Pitt Street Research Life Sciences Conference is happening on September 19, 2024!
The Life Sciences sector in Australia and New Zealand continues to mature in 2024. In spite…
Unless you're a professional dermatologist, you may not have ever heard of Photodynamic Therapy, let alone thought of it as an option to fight cancer as Invion (ASX:IVX) is doing.
Invion…